EDAP TMS of Lyon, France, has appointed John Rewcastle, Ph.D., as international medical director.
Rewcastle's duties will include the company's U.S. clinical trial for Ablatherm, a high-intensity focused ultrasound (HIFU) device for the treatment of prostate cancer.
Most recently, he has worked with cryoablation vendor Endocare of Irvine, CA, in establishing cryoablation as a treatment option for localized prostate cancer.
By AuntMinnie.com staff writers
June 28, 2007
Related Reading
HealthTronics terminates EDAP agreement, April 10, 2007
EDAP TMS to push European marketing efforts, August 4, 2006
EDAP extends Japanese presence, names Laronze as VP, February 16, 2006
EDAP taps Varona as medical director, December 7, 2005
HealthTronics taps new president and CEO, December 5, 2005
Copyright © 2007 AuntMinnie.com